课题基金 / 基金详情

Pharmacology of Stimulant Choice

Pharmacology of Stimulant Choice
兴奋剂选择的药理学
批准号:
10585535
负责人:
Matthew L Banks
金额:
$34.93万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-15 至 2028-02-29

项目摘要

项目成果

Matthew L Banks的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This new R01 application proposes a systematic series of experiments focused on drug-choice procedures in male and female rats to evaluate the muscarinic acetylcholine receptor (mAChR)1 agonist VU0364572 as a candidate medication for treatment of cocaine and methamphetamine use disorder. This application is founded on the premise that stimulant use disorder in humans can be studied using preclinical assays of drug-vs-food choice that model clinical aspects of behavioral misallocation and decision making between concurrently available drugs and an alternative nondrug reinforcer. We propose to determine 1) VU0364572 effects on cocaine-food and cocaine-social choice, 2) VU0364572 effects on methamphetamine-food and methamphetamine-social choice, and 3) VU0364572 effects on nucleus accumbens and prefrontal cortex dopamine release using dLight.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cell type transcriptional mechanisms of polysubstance choice
  • 批准号:
    10740057
  • 项目类别:
  • 资助金额:
    $44.31万
  • 财政年份:
    2023
  • 负责人:
    Matthew L Banks
  • 依托单位:
The role of negative reinforcement in drug abuse
  • 批准号:
    10244062
  • 项目类别:
  • 资助金额:
    $21.91万
  • 财政年份:
    2021
  • 负责人:
    Matthew L Banks
  • 依托单位:
The role of negative reinforcement in drug abuse
  • 批准号:
    10356175
  • 项目类别:
  • 资助金额:
    $19.41万
  • 财政年份:
    2021
  • 负责人:
    Matthew L Banks
  • 依托单位:
Behavioral effects of NMDA antagonist/opioid agonist combinations
  • 批准号:
    9066613
  • 项目类别:
  • 资助金额:
    $38.99万
  • 财政年份:
    2014
  • 负责人:
    Matthew L Banks
  • 依托单位: